» Authors » Pasquale Perillo

Pasquale Perillo

Explore the profile of Pasquale Perillo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 68
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nevola R, Tortorella G, Rosato V, Rinaldi L, Imbriani S, Perillo P, et al.
Biology (Basel) . 2023 Jul; 12(7). PMID: 37508414
Several chronic liver diseases are characterized by a clear gender disparity. Among them, hepatocellular carcinoma (HCC) shows significantly higher incidence rates in men than in women. The different epidemiological distribution...
2.
Nevola R, Delle Femine A, Rosato V, Kondili L, Alfano M, Mastrocinque D, et al.
Cancers (Basel) . 2023 Jun; 15(11). PMID: 37296912
Despite maximizing techniques and patient selection, liver resection and ablation for HCC are still associated with high rates of recurrence. To date, HCC is the only cancer with no proven...
3.
Nevola R, Beccia D, Rosato V, Ruocco R, Mastrocinque D, Villani A, et al.
Int J Mol Sci . 2023 Apr; 24(8). PMID: 37108816
Hepatitis B virus (HBV) is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Despite the advent of vaccines and potent antiviral agents able to suppress viral replication,...
4.
Nevola R, Criscuolo L, Beccia D, Delle Femine A, Ruocco R, Imbriani S, et al.
World J Gastroenterol . 2023 Feb; 29(5):800-814. PMID: 36816617
Since the first identification in December of 2019 and the fast spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, it has represented a dramatic global public health concern....
5.
Nevola R, Rosato V, Conturso V, Perillo P, Le Pera T, Del Vecchio F, et al.
Biology (Basel) . 2022 Jun; 11(6). PMID: 35741326
People who use drugs (PWUDs) are a crucial population in the global fight against viral hepatitis. The difficulties in linkage to care, the low adherence to therapy, the frequent loss...
6.
Rosato V, Nevola R, Conturso V, Perillo P, Mastrocinque D, Pappalardo A, et al.
Biology (Basel) . 2022 Jun; 11(6). PMID: 35741321
People who use drugs (PWUDs) are generally considered "hard-to-treat" patients, due to adherence to HCV antiviral therapy or re-infection concerns. Linkage-to-care still remains a significant gap for HCV elimination, worsened...
7.
Rosato V, Kondili L, Nevola R, Perillo P, Mastrocinque D, Aghemo A, et al.
Viruses . 2022 May; 14(5). PMID: 35632837
Free-of-charge HCV screening in some key populations and in 1969-1989 birth cohorts has been funded in Italy as the first step to diagnosing individuals who are infected but asymptomatic. The...
8.
Rosato V, Ascione A, Nevola R, Fracanzani A, Piai G, Messina V, et al.
J Viral Hepat . 2021 Sep; 29(1):26-34. PMID: 34582610
The long-term changes of liver stiffness (LS) in patients who achieve viral clearance after direct-acting anti-HCV therapy remain undefined. We conducted a multicentre prospective study to investigate this aspect. Patients...
9.
Nevola R, Rosato V, Perillo P, Esposito N, Massa D, Frascino A, et al.
JGH Open . 2020 Dec; 4(6):1240-1241. PMID: 33319066
A 72-year-old man with polycystic liver disease and unexplained shock was admitted to our Emergency Department. The presence of turgidity in the jugular veins and acute prerenal kidney failure led...